S&P 500 7,656.98 +0.86%
Nasdaq 26,333.04 +0.96%
S&P/TSX 35,697.49 +0.54%
Apple 332.27 +1.75%
Nvidia 218.29 −0.03%
Microsoft 495.63 +0.65%
Shopify 178.41 +1.87%
Royal Bank 285.20 +0.08%
CAD/USD 0.7210 −0.25%
CLOSED · 01:05 ET
Market ClerkRecap
Sat Sep 12 · markets closed2 signals on Sep 11229 insider buys this week · $284.4MCIRO short report next: Sep 14The week ahead

ENGN

enGene Therapeutics Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
1.80
+0.03 +1.69%
USD · close Sep 11

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

One year, everything drawn on

251 SESSIONS · DAILY CLOSES
138.884.730.58Sep 8 · 10-Q filed (Q3 2026)Sep 8 · 10-Q filed (Q2 2026)Sep 8 · 10-Q filed (Q1 2026)Dec 22 · 10-K filed (FY 2025)Dec 22 · 10-K filed (Q4 2025)Sep 8 · 10-Q filed (Q3 2025)Sep 8 · 10-Q filed (Q2 2025)Sep 8 · 10-Q filed (Q1 2025)Dec 22 · 10-K filed (FY 2024)Dec 22 · 10-K filed (Q4 2024)SEP 2025OCTJAN 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-09-12
Shorts (latest report): 1.5M short · −238K last period
Every line of the math
90PASS

Congress is trading it

No STOCK Act disclosure names ENGN.

Insider activity

No open-market insider filings on ENGN.
Watch ENGN. Know when insiders buy.
One email the day a filing lands. Free.